Dexamethasone for the Prevention of Postoperative Nausea and Vomiting: A Quantitative Systematic Review
Top Cited Papers
- 1 January 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 90 (1) , 186-194
- https://doi.org/10.1097/00000539-200001000-00038
Abstract
When there is a high risk of postoperative nausea and vomiting, a single prophylactic dose of dexamethasone is antiemetic compared with placebo, without evidence of any clinically relevant toxicity in otherwise healthy patients. Late efficacy seems to be most pronounced. It is very likely that the best prophylaxis of postoperative nausea and vomiting currently available is achieved by combining dexamethasone with a 5-HT3 receptor antagonist. Optimal doses of this combination need to be identified.Keywords
This publication has 45 references indexed in Scilit:
- Surrogate OutcomesAnesthesiology, 1999
- Effect of propofol for induction and ondansetron with or without dexamethasone for the prevention of nausea and vomiting after major gynecologic surgeryJournal of Clinical Anesthesia, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Adrenal Function Following High-Dose Steroids in Ovarian Cancer PatientsGynecologic Oncology, 1995
- Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapyThe Lancet, 1991
- The current role of anti-emetic drugs in oncology: a recent revolution in patient symptom controlCancer Treatment Reviews, 1991
- An Assessment of Clinically Useful Measures of the Consequences of TreatmentNew England Journal of Medicine, 1988
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Methylprednisolone as an antiemetic during cancer chemotherapy—a pilot studyGynecologic Oncology, 1980